About G Scott Gazelle, MD, PhD, MPH
Clinical Interests:
- Breast Cancer
- Cancer Screening
- Colon and rectal cancer
- Percutaneous Tumor Ablation
Treats:
- Adult
Locations
Medical Education
- MD, Case Western Reserve
- MPH, Harvard T.H. Chan School of Public Health*
- PhD, Harvard University*
- Residency, Case Western Reserve University/MetroHealth Medical Center
- Residency, University Hospitals of Cleveland (Ohio)
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Diagnostic Radiology, American Board of Radiology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
My research focuses on the clinical, economic and policy implications of new medical technologies. A major focus of my work has been on cancer prevention and control, principally related to breast, lung and colorectal cancer.
Publications
-
Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Cost-Effectiveness of Breast MRI and Screen-Film Mammography for Screening BRCA1 Gene Mutation Carriers. Radiology, 2010; 254: 793-800
McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS. Cost-effectiveness of Computed Tomography Screening for Lung Cancer in the United States. Journal of Thoracic Oncology, 2011; 6: 1841-1848
Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Chubiz JEC, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis. Cancer; 2012; 118: 2021-2030
Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM. Rescreening of Individuals with a Negative Colonoscopy: Results from a Microsimulation Model. Annals of Internal Medicine, 2012; 157: 611-620
Cott Chubitz JE, Lee JM, Gilmore ME, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS. Cost-Effectiveness of Alternating Magnetic Resonance Imaging and Digital Mammography Screening in BRCA1 and BRCA2 Gene Mutation Carriers. Cancer, 2013; 119:1266-1276